NCT07731906

Brief Summary

The goal of this randomized controlled trial is to evaluate the effectiveness and feasibility of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in migrants with posttraumatic stress symptoms attending an adult education center (CPIA Salerno) in Italy. The main questions it aims to answer are:

  • Do participants who receive the EMDR-IGTP-OTS intervention show greater reductions in posttraumatic stress symptoms compared with participants assigned to a control condition?
  • Does the intervention lead to improvements in psychological distress and broader psychological functioning over time?
  • Is the EMDR-IGTP-OTS intervention feasible in an adult education setting, as indicated by treatment completion and adherence to the intervention protocol? Researchers will compare participants receiving the EMDR-IGTP-OTS group intervention with participants assigned to a control condition to determine whether the intervention is effective in reducing posttraumatic stress symptoms and psychological distress. Participants will:
  • Complete questionnaires assessing posttraumatic stress symptoms and psychological distress before the intervention, after the intervention, and at follow-up.
  • Participate in four structured group sessions of EMDR-IGTP-OTS delivered on consecutive days.
  • Be monitored for treatment completion and protocol adherence throughout the intervention period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 3, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
Last Updated

July 28, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

July 20, 2026

Last Update Submit

July 23, 2026

Conditions

Keywords

EMDR-IGTP-OTSPosttraumatic Stress SymptomsMigrantsOngoing Traumatic StressTrauma-Focused InterventionRandomized Controlled TrialEducational Setting

Outcome Measures

Primary Outcomes (2)

  • Change in posttraumatic stress symptoms assessed by the Impact of Event Scale-Revised (IES-R)

    The Impact of Event Scale-Revised (IES-R) is a 22-item self-report measure assessing posttraumatic stress symptoms across three domains: intrusion, avoidance, and hyperarousal. Total scores range from 0 to 88, with higher scores indicating greater symptom severity.

    Baseline, immediately after completion of the 4-day intervention (Day 4), and 30 days after completion of the intervention.

  • Change in posttraumatic stress symptoms assessed by the Short PTSD Rating Interview (SPRINT)

    The Short PTSD Rating Interview (SPRINT) is an eight-item measure assessing posttraumatic stress symptom severity, distress, and functional impairment. Total scores range from 0 to 32, with higher scores indicating greater symptom severity.

    Baseline, immediately after completion of the 4-day intervention (Day 4), and 30 days after completion of the intervention.

Secondary Outcomes (2)

  • Change in global psychological distress assessed by the Clinical Outcomes in Routine Evaluation-10 (CORE-10)

    Baseline, immediately after completion of the 4-day intervention (Day 4), and 30 days after completion of the intervention.

  • Protocol adherence to the EMDR-IGTP-OTS intervention

    Assessed during each of the four consecutive intervention sessions (Days 1-4).

Study Arms (2)

EMDR-IGTP-OTS intervention group

EXPERIMENTAL

Participants assigned to this arm received the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS), a structured group intervention designed to reduce posttraumatic stress symptoms and trauma-related distress. The intervention consisted of four group sessions delivered on consecutive days.

Behavioral: Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS)

Waitlist Control Condition

NO INTERVENTION

Participants assigned to this arm were placed on a waitlist and did not receive the EMDR-IGTP-OTS intervention during the study comparison period.

Interventions

The Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) is a structured group behavioral intervention based on the principles of Eye Movement Desensitization and Reprocessing (EMDR). The protocol is specifically adapted for individuals exposed to ongoing traumatic stress and is designed for delivery in group settings. The intervention consists of four structured group sessions delivered on consecutive days, following standardized procedures that include trauma processing, a form of art therapy, and bilateral stimulation techniques. The intervention aims to reduce posttraumatic stress symptoms and trauma-related distress.

EMDR-IGTP-OTS intervention group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Enrollment in courses at CPIA Salerno (adult education center).
  • Age ≥16 years.
  • Sufficient Italian or English language proficiency to complete study procedures.
  • Provision of informed consent.
  • Clinically significant posttraumatic stress symptoms, defined as an Impact of Event Scale-Revised (IES-R) score ≥24 or a Short PTSD Rating Interview (SPRINT) score ≥14 at baseline.

You may not qualify if:

  • Current self-harm behavior or suicidal or homicidal ideation.
  • Substance abuse.
  • Psychotic disorders, bipolar disorders, or organic mental disorders.
  • Lack of adequate structural or functional support.
  • Significant cognitive impairment affecting participation in study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Provinciale Istruzione Adulti Salerno "Paulo Freire"

Salerno, Italy, 84131, Italy

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticTrauma and Stressor Related Disorders

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking was used due to the nature of the behavioral intervention. Participants assigned to the EMDR-IGTP-OTS group and intervention providers were aware of treatment allocation. Investigators involved in intervention delivery were also aware of group assignment. Outcome measures were collected through standardized participant-reported questionnaires.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to either the EMDR-IGTP-OTS intervention group or a waitlist control condition. The study followed a parallel-group design, with both groups assessed at baseline, post-intervention, and 30-day follow-up. Participants assigned to the waitlist control condition did not receive the intervention during the study comparison period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2026

First Posted

July 28, 2026

Study Start

December 3, 2025

Primary Completion

February 26, 2026

Study Completion

May 28, 2026

Last Updated

July 28, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data underlying the reported results will be shared, including demographic characteristics, baseline clinical characteristics, intervention allocation, and outcome measures collected at baseline, post-intervention, and 30-day follow-up. Shared outcome data will include scores from the Impact of Event Scale-Revised (IES-R), Short PTSD Rating Interview (SPRINT), and Clinical Outcomes in Routine Evaluation-10 (CORE-10).

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Beginning immediately following publication, with no planned end date.
Access Criteria
Deidentified individual participant data and supporting documentation (study protocol, statistical analysis plan, and analytic code) will be publicly available through the study's Open Science Framework (OSF) repository following publication of the primary study results. Data will be shared in a deidentified format in accordance with the informed consent provided by participants, applicable privacy regulations, and ethical approval.

Locations